Abstract
Vertebral fractures (VFs) are highly prevalent among community-dwelling Chinese postmenopausal women aged 50 and older. This study highlights that osteoporosis prevalence is significantly higher when fragile fractures are included in the clinical diagnosis, revealing a major gap in current screening practices that rely solely on bone mineral density (BMD).
Introduction
Osteoporosis is often termed a "silent" epidemic, with vertebral fractures (VFs) being its most frequent manifestation. Unlike hip fractures, VFs are frequently asymptomatic, leading many patients to dismiss back pain or height loss as normal signs of aging. Consequently, a vast number of VFs go undiagnosed. The ChiVOS study (China Vertebral and Osteoporosis Study) was designed to establish a nationwide baseline for VF prevalence among urban-dwelling postmenopausal women in China, identifying key risk factors beyond simple bone mineral density (BMD).
Methodology
The researchers utilized a two-stage cluster sampling approach across five geographic regions: East, West, South, North, and Central China. Within these regions, 10 Tier-3 hospitals were selected, and community health records were used to randomly invite women aged $\ge 50$ for screening.
Clinical assessments included:
- BMD Measurement: Conducted via dual-energy X-ray absorptiometry (DXA) at the lumbar spine and hip.
- Radiographic Adjudication: Lateral spine X-rays were evaluated using Genant’s semi-quantitative method to grade fractures based on vertebral height reduction.
- Statistical Analysis: Multivariate logistic regression identified significant risk factors.
Key Findings
The Prevalence Landscape
The study found an overall VF prevalence of 14.7% among the 2,634 women in the Full Analysis Set. Interestingly, geographic location played a minimal role; there was no statistically significant difference in prevalence between North and South China, suggesting a uniform risk across urban centers.
The "Normal BMD" Trap
A critical insight from the study is the limitation of relying solely on T-scores. Approximately 7.0% of women with normal BMD still exhibited prevalent VFs. When clinical criteria—including the presence of fragile fractures—were applied, the prevalence of osteoporosis rose from 32.9% (BMD alone) to between 40.8% and 48.2%. This suggests that many women who "pass" a BMD test are still clinically osteoporotic due to existing fractures.
The Age Escalator
Age emerged as the most potent predictor of VFs. The prevalence increases dramatically as women age, jumping from less than 1% in the early 50s to over 35% for those over 80.
Risk Factors and Clinical Implications
Multivariate analysis identified several key risk factors for VFs, including age $\ge 65$ (OR 2.57), densitometric osteoporosis (OR 2.52), and a prior history of hip fracture (OR 2.28). Interestingly, dominantly labor work (OR 1.56) and significant height decrease (>3cm, OR 1.36) were also notable predictors.
Most identified fractures were mild (49.7%) and occurred in the thoracic region (62.4%). The high prevalence of fractures in women with non-osteoporotic BMD scores underscores the need for a shift toward clinical diagnosis that incorporates fracture history and physical indicators like height loss.
Conclusion
The ChiVOS study underscores a significant public health challenge in China. While BMD is a vital metric, it is not an absolute safeguard against fractures. Early screening programs must look beyond T-scores to include radiographic assessments and clinical history to capture the "silent" fractures that precede more debilitating injuries. Future longitudinal research is necessary to track VF progression and evaluate the long-term impact of improved diagnostic criteria.
Summary updated